IRIS
LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.632
EU - Europa 9.455
AS - Asia 5.628
SA - Sud America 996
AF - Africa 298
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 28.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.457
CN - Cina 1.945
RU - Federazione Russa 1.915
GB - Regno Unito 1.862
SG - Singapore 1.746
IT - Italia 1.202
IE - Irlanda 1.177
BR - Brasile 834
DE - Germania 765
SE - Svezia 715
UA - Ucraina 545
VN - Vietnam 541
FR - Francia 516
HK - Hong Kong 444
FI - Finlandia 388
KR - Corea 312
IN - India 196
ZA - Sudafrica 114
CA - Canada 94
NL - Olanda 74
TR - Turchia 69
ES - Italia 64
BD - Bangladesh 63
AR - Argentina 57
IQ - Iraq 53
CI - Costa d'Avorio 49
MX - Messico 46
PL - Polonia 42
NG - Nigeria 41
JP - Giappone 39
BE - Belgio 36
KE - Kenya 30
EC - Ecuador 29
CZ - Repubblica Ceca 28
AT - Austria 26
PK - Pakistan 24
TH - Thailandia 22
VE - Venezuela 21
CO - Colombia 20
ID - Indonesia 20
GR - Grecia 18
AU - Australia 15
EG - Egitto 14
TN - Tunisia 14
UZ - Uzbekistan 14
IL - Israele 13
MA - Marocco 13
PH - Filippine 13
SA - Arabia Saudita 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
KZ - Kazakistan 10
RO - Romania 10
AZ - Azerbaigian 9
CL - Cile 9
JM - Giamaica 9
CH - Svizzera 8
IR - Iran 8
DZ - Algeria 7
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
MY - Malesia 7
NP - Nepal 7
PY - Paraguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
HR - Croazia 5
HU - Ungheria 5
OM - Oman 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
CY - Cipro 4
HN - Honduras 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GY - Guiana 3
LB - Libano 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MM - Myanmar 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
Totale 28.009
Salva come PNG Salva come JPEG
Città #
Southend 1.606
Dallas 1.520
Fairfield 1.169
Dublin 1.143
Ashburn 997
Singapore 974
Chandler 599
Woodbridge 543
Moscow 537
Santa Clara 493
Houston 467
Beijing 459
Hefei 435
Seattle 429
Jacksonville 427
Hong Kong 426
Wilmington 424
Cambridge 395
Siena 360
San Jose 356
Menlo Park 308
Seoul 305
Ann Arbor 291
Helsinki 237
Princeton 209
The Dalles 208
Los Angeles 163
Nanjing 155
New York 151
Lauterbourg 147
Ho Chi Minh City 144
Milan 138
Dong Ket 125
Munich 116
Council Bluffs 114
Hanoi 110
Johannesburg 101
Boardman 98
Florence 98
Dearborn 93
Buffalo 86
Vimercate 78
San Diego 77
São Paulo 69
San Mateo 64
Nanchang 60
Bengaluru 57
Orem 53
Abidjan 49
Shanghai 49
Turku 47
Columbus 46
Shenyang 44
Brooklyn 42
London 41
Chicago 40
Málaga 40
Frankfurt am Main 39
Abuja 38
Redondo Beach 36
Brussels 35
Tokyo 34
Toronto 34
Lappeenranta 33
Warsaw 33
Rome 32
Changsha 31
San Francisco 31
Amsterdam 30
Poggiomarino 29
Denver 27
Hebei 27
Nuremberg 27
Izmir 26
Lancaster 26
Mumbai 26
Tianjin 26
Düsseldorf 24
Guangzhou 24
Jinan 24
Montreal 24
Rio de Janeiro 24
Kunming 23
Phoenix 22
Belo Horizonte 21
Chennai 21
Jiaxing 21
Norwalk 21
Baghdad 19
Da Nang 19
Ankara 18
Poplar 18
Pune 18
Stockholm 18
Fremont 17
Washington 17
Zhengzhou 17
Dhaka 16
Falls Church 16
Manchester 16
Totale 19.090
Salva come PNG Salva come JPEG
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 414
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 393
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 393
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 382
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 358
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 353
Antirheumatic agents in covid-19: is IL-6 the right target? 352
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 330
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 313
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 312
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 308
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 307
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 304
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 298
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 294
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 294
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 288
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 283
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 278
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 277
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 268
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 257
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 257
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 256
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 255
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 253
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 250
Torsades de Pointes in patients with polymyalgia rheumatica 246
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 241
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 240
The role of P2X7 receptors in tissue fibrosis: a brief review 238
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 237
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 237
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 234
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 233
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 232
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 231
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 230
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 229
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 228
Statins and the joint: multiple targets for a global protection? 227
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 226
Human rheumatoid synoviocytes express functional P2X7 receptors 225
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 223
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 222
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 221
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 219
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 217
Connective tissue diseases and cardiac rhythm disorders: an overview 215
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 211
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 210
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 206
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 200
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 198
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 197
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 197
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 197
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 196
Pathogenesis of the novel autoimmune-associated long-QT syndrome 196
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 195
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 194
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 191
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 188
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 185
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 184
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 181
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 180
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 180
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 179
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 176
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 175
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 174
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 174
Photopheresis immunomodulation after heart transplantation. 173
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 171
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 170
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 170
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 169
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 167
Homocysteine and Raynaud’s phenomenon: a review 167
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 163
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 163
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 162
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans. 162
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 161
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 159
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 159
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 159
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 158
Homocysteine and P wave dispersion in patients with heart transplantation 157
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 153
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 152
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 148
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 147
Editorial: Insights in general cardiovascular medicine: 2022 145
Hyperhomocysteinemia, inflammation and autoimmunity 142
null 141
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 139
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 138
Totale 22.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021644 0 0 0 0 0 0 0 0 0 220 208 216
2021/20221.894 135 220 91 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/20254.348 89 201 365 256 491 276 197 273 347 214 442 1.197
2025/20269.344 860 1.579 1.046 1.218 1.821 464 1.210 300 373 473 0 0
Totale 28.473